Jamie Mcgarvey Joins Astellas Pharma Inc. (ALPMY) Corporate Affairs Team

NORTHBROOK, Ill., Sept 15, 2015 /PRNewswire/ -- Astellas Pharma today announced that Jamie McGarvey has been named to the role of senior manager, employee communications within the Corporate Affairs Department. She will report to Jennifer Saputo, associate director of employee communications.

Jamie will be responsible for developing and implementing employee communications throughout the US and the Americas, including executive support.

"Astellas recognizes that an informed and engaged employee base helps drive our overall success," said Jeff Winton, senior vice president, Corporate Affairs, and chief communications officer. "Jamie's broad experience in employee communications and change management will help strengthen our award-winning workplace and corporate culture."

Most recently, McGarvey served as communications lead for global process and systems implementation programs at Baxter International Inc. She has also worked in various internal and external communications roles in Chicago at US Cellular Corporation and Swedish Covenant Hospital. McGarvey earned a Bachelor's Degree in English from Harding University in Searcy, Arkansas.

The Corporate Affairs Department at Astellas combines Corporate, Employee and Business Communications; Government Affairs and Public Policy, Astellas US Foundation, Stakeholder Engagement, Corporate Branding, Corporate Social Responsibility and Corporate Events to unify the Astellas voice across all internal and external stakeholders.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS. Visit our Facebook page at www.facebook.com/AstellasUS.

Photo - http://photos.prnewswire.com/prnh/20150915/266812

Logo - http://photos.prnewswire.com/prnh/20140416/84970


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/jamie-mcgarvey-joins-astellas-pharma-corporate-affairs-team-300143469.html

SOURCE Astellas Pharma

Suggested Articles

Gilead Sciences is paying Nurix $45 million upfront in a deal that could reach $2.3 billion in value if all milestones are met and royalties realized.

In mice, Kymera's lead drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.

The report features testimony that some NHS bodies are “actively instructed not to deal with industry by their local leadership.”